Michael Ausserlechner

Head of 3D Bioprinting Lab

Medical University of Innsbruck
Country flagAustria

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Michael Ausserlechner is the Head of the 3D Bioprinting Lab at Innsbruck Medical University, Austria. His research primarily focuses on bioprinting techniques for creating vascularized organ models and investigating mitochondrial function and dynamics in various cellular contexts. He has authored several recent articles addressing bioprinting for drug testing, mitochondrial metabolism, and lipidomic changes in fibroblasts related to fatty acid oxidation disorders.

Articles (9)

3D bioprinting enables the fabrication of human organ models that can be used for various fields of biomedical research, including oncology and infection biology. An important challenge, however, remains the generation of vascularized, perfusable 3D models that closely simulate natural physiology. Here, a novel direct ink writing (DIW) approach is described that can produce vascularized organ models without using sacrificial materials during fabrication. The high resolution of the method allows the one‐step generation of various sophisticated hollow geometries. This sacrificial‐free DIW (SF‐DIW) approach is used to fabricate hepatic metastasis models of various cancer types and different formats for investigating the cytostatic activity of anti‐cancer drugs. To this end, the models are incorporated into a newly developed perfusion system with integrated micropumps and an agar casting step that improves the physiological features of the bioprinted tissues. It is shown that the hepatic environment of the tumor models is capable of activating a prodrug, which inhibits breast cancer growth. This versatile SF‐DIW approach is able to fabricate complicated perfusable constructs or microfluidic chips in a straightforward and cost‐efficient manner. It can also be easily adapted to other cell types for generating vascularized organ tissues or cancer models that may support the development of new therapeutics.

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Judith Hagenbuchner

Head 3D Bioprinting Lab

Medical University of Innsbruck

AUSTRIA
View details

Ute Spiekerkoetter

University Medical Center Freiburg

GERMANY
View details

Sabzali Javadov

-

UNITED STATES
View details

Christian Ploner

Laboratory head and group leader "Human Wound Healing"

Medical University of Innsbruck

AUSTRIA
View details

Jens Kurreck

-

GERMANY
View details

Thomas Müller

Medical University of Innsbruck

AUSTRIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.